1. Home
  2. GBIO vs DIBS Comparison

GBIO vs DIBS Comparison

Compare GBIO & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • DIBS
  • Stock Information
  • Founded
  • GBIO 2016
  • DIBS 2000
  • Country
  • GBIO United States
  • DIBS United States
  • Employees
  • GBIO N/A
  • DIBS N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • DIBS Catalog/Specialty Distribution
  • Sector
  • GBIO Health Care
  • DIBS Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • DIBS Nasdaq
  • Market Cap
  • GBIO 165.5M
  • DIBS 175.8M
  • IPO Year
  • GBIO 2020
  • DIBS 2021
  • Fundamental
  • Price
  • GBIO $1.67
  • DIBS $4.00
  • Analyst Decision
  • GBIO Strong Buy
  • DIBS Buy
  • Analyst Count
  • GBIO 2
  • DIBS 1
  • Target Price
  • GBIO $7.50
  • DIBS $8.00
  • AVG Volume (30 Days)
  • GBIO 137.7K
  • DIBS 102.2K
  • Earning Date
  • GBIO 11-06-2024
  • DIBS 11-08-2024
  • Dividend Yield
  • GBIO N/A
  • DIBS N/A
  • EPS Growth
  • GBIO N/A
  • DIBS N/A
  • EPS
  • GBIO N/A
  • DIBS N/A
  • Revenue
  • GBIO $18,582,000.00
  • DIBS $86,409,000.00
  • Revenue This Year
  • GBIO $99.36
  • DIBS $5.82
  • Revenue Next Year
  • GBIO N/A
  • DIBS $7.96
  • P/E Ratio
  • GBIO N/A
  • DIBS N/A
  • Revenue Growth
  • GBIO 514.08
  • DIBS N/A
  • 52 Week Low
  • GBIO $1.06
  • DIBS $3.81
  • 52 Week High
  • GBIO $4.65
  • DIBS $6.30
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 32.17
  • DIBS 35.33
  • Support Level
  • GBIO $2.14
  • DIBS $3.97
  • Resistance Level
  • GBIO $2.57
  • DIBS $4.16
  • Average True Range (ATR)
  • GBIO 0.19
  • DIBS 0.12
  • MACD
  • GBIO -0.04
  • DIBS -0.01
  • Stochastic Oscillator
  • GBIO 1.23
  • DIBS 3.57

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About DIBS 1stdibs.com Inc.

1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.

Share on Social Networks: